Daniel Forton

Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study

Rachael A Evans, Hamish McAuley, Ewen M. Harrison et al. · The Lancet Respiratory Medicine · 2021 · 659 citations · Full text

Medicine, Health Sciences, Psychiatry +17

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 466 citations

Medicine, Internal Medicine, Pharmacotherapy +12

Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease

Daniel Forton, Howard C. Thomas, Christine Murphy et al. · Hepatology · 2002 · 448 citations · Full text

Medicine, Infectious Diseases, Neurology +17

Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study

Rachael A Evans, Olivia C. Leavy, Matthew Richardson et al. · The Lancet Respiratory Medicine · 2022 · 424 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacotherapy +16

Efficacy of Sofosbuvir Plus Ribavirin With or Without Peginterferon-Alfa in Patients With Hepatitis C Virus Genotype 3 Infection and Treatment-Experienced Patients With Cirrhosis and Hepatitis C Virus Genotype 2 Infection

Graham R. Foster, Stephen Pianko, Ashley Brown et al. · Gastroenterology · 2015 · 250 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17